PT - JOURNAL ARTICLE AU - Kannian, Priya AU - Mahanathi, Pasuvaraj AU - Gracemary, Arul AU - Kumarasamy, Nagalingeswaran AU - Challacombe, Stephen J. TI - Mucosal immunity and antibody anergy in COVID-exposed Covishield vaccinees AID - 10.1101/2022.09.06.22279625 DP - 2022 Jan 01 TA - medRxiv PG - 2022.09.06.22279625 4099 - http://medrxiv.org/content/early/2022/09/06/2022.09.06.22279625.short 4100 - http://medrxiv.org/content/early/2022/09/06/2022.09.06.22279625.full AB - Knowledge is limited on mucosal immunity induction and longitudinal responses to vaccination against SARS-CoV2. Here, we determined serum/salivary antibodies and cytokines after three Covishield vaccine doses. Sera from 205 healthcare workers (HCWs) one-month after first- dose; one-, three- and six-months after second-dose; paired sera and stimulated whole mouth fluid (SWMF) from 10 HCWs one-, three- and six-months after third-dose were tested for anti- spike SARS-CoV2 antibodies by ECLIA and for cytokines by ELISA/cytokine bead arrays. One-month after second-dose, antibodies had increased significantly (6-fold) in COVID-naïve group, but declined (1.5-fold) in those previously exposed to COVID. At one-month after first- dose, IL-10 levels were statistically higher in the previously COVID-exposed group compared to COVID-naïve group (p<0.02). Breakthrough infections were 44% in COVID-naïve group, while re-infections were 27% in COVID-exposed group (p<0.02). Proinflammatory cytokines–IL- 17/IL-21 at one-month after first- and second-doses, and memory cytokines–IL-7/IL-15 at three- and six-months after second-dose were minimal. Antibodies spiked at one-month after third- dose and declined by three- and six-months after third-dose similar to post-second-dose. Paired sera and SWMF at one- and six-months after third-dose lacked adaptive immunity cytokine expression. Innate immunity cytokines (MIG, MCP-1, IL-8, TNF-α, IL-6, IL-1β) showed a declining trend in serum, but were sustained in SWMF. Thus, our findings suggest that first-dose acts as an antibody boost, while second-dose induces antibody anergy in the previously COVID- exposed group. Rapidly declining antibodies and minimal T cell cytokines raises concerns over their durability in subsequent virus exposures. Sustained innate cytokines emanating from the oral mucosa warrant further in-depth explorations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by Intramural GPR funds [VHS/RG/2021/003], The Voluntary Health Services, Chennai, India and Indo-UK Collaborative project [BT/IN/Indo-UK/02/PK/2021-22 (Computer No. 13580)], Department of Biotechnology, Government of India, New Delhi, India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:VHS - Institutional Ethics Committee of The Voluntary Health Services Hospital gave approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.